What Are the Advantages of Myocet Over Conventional Doxorubicin?
The primary advantage of Myocet over conventional doxorubicin is its reduced cardiotoxicity. This makes it a safer option for patients with pre-existing heart conditions or those who require prolonged treatment. Additionally, the liposomal formulation can improve the drug's efficacy by enhancing its delivery to tumor cells.